Addressing public questioning and concerns about vaccination in South Africa: A guide for healthcare workers

Vaccine

Volumn 30, Issue SUPPL.3, 2012, Pages

  Burnett, Rosemary J ^a   Larson, Heidi J ^b   Moloi, Molelekeng H ^a   Tshatsinde, E Avhashoni ^a   Meheus, André ^c   Paterson, Pauline ^b   François, Guido ^c  

^a SEFAKO MAKGATHO HEALTH SCIENCES UNIVERSITY   (South Africa)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Anti vaccination; South Africa; Vaccination

Indexed keywords

BCG VACCINE; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; ORAL POLIOMYELITIS VACCINE; PNEUMOCOCCUS VACCINE; ROTAVIRUS VACCINE;

AUTISM; CAREGIVER; DIPHTHERIA; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG INDUSTRY; DRUG SAFETY; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HEALTH PROGRAM; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; INFLUENZA; MASS MEDIUM; MEASLES; MEASLES VACCINATION; MEDICAL INFORMATION; MUMPS; PARENT; PERTUSSIS; PNEUMOCOCCAL INFECTION; POLIOMYELITIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; ROTAVIRUS INFECTION; RUBELLA; SOUTH AFRICA; TETANUS; VACCINATION;

HEALTH EDUCATION; HUMANS; PATIENT ACCEPTANCE OF HEALTH CARE; SOUTH AFRICA; VACCINATION; VACCINES;

EID: 84865618857     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.03.037     Document Type: Review

References (69)

1. François G., Duclos P., Margolis H., Lavanchy D., Siegrist C.A., Meheus A., et al. Vaccine safety controversies and the future of vaccination programs. Pediatr Infect Dis J 2005, 24(November (11)):953-961.
2. François G., Kramvis A., Van Hal G., Lambkin A., Dochez C., Meheus A. Vaccination in the line of fire. S Afr J Epidemiol Infect 2008, 23(1):53-57.
3. Larson H.J., Cooper L.Z., Eskola J., Katz S.L., Ratzan S. Addressing the vaccine confidence gap. Lancet 2011, 378(August 6 (9790)):526-535.
4. World Health Organization Polio vaccines and polio immunization in the pre-eradication era: WHO position paper. Wkly Epidemiol Rec 2010, 85(23):213-228. Available from [accessed February 2012].
5. Independent Monitoring Board of the Global Polio Eradication Initiative. Available from ; July 2011 [accessed February 2012]. http://www.polioeradication.org/Portals/0/Document/Aboutus/Governance/IMB/3rdIMBMeeting/IMB.Report.July.pdf.
6. World Health Organization Measles vaccines: WHO position paper. Wkly Epidemiol Rec 2009, 84(35):349-360. Available from [accessed February 2012].
7. World Health Organization Measles outbreaks and progress towards meeting measles pre-elimination goals: WHO African Region, 2009-2010. Wkly Epidemiol Rec 2011, 86(April 1 (14)):129-136.
8. World Health Organization Increased transmission and outbreaks of measles, European Region, 2011. Wkly Epidemiol Rec 2011, 86(December 2 (49)):559-564.
9. Health Systems Trust. The District Health Barometer 2008/09. Part A: indicator comparison by districts. Output indicators: immunisation. Available from ; 2010 [accessed February 2012]. http://www.hst.org.za/sites/default/files/dhb0809_31.pdf.
10. South African Department of Health. Expanded Programme on Immunisation - EPI (SA) Revised Childhood Immunisation Schedule from April 2009. Available from ; 2009 [accessed February 2012]. http://www.kznhealth.gov.za/vaccinations.pdf.
11. National Institute for Communicable Diseases. Communicable Diseases Surveillance Bulletin. Available from ; 2011 March [accessed February 2012]. http://www.nicd.ac.za/assets/files/Communicable%20Diseases%20Surveillance%20Bulletin%20March%202011.pdf.
12. Corrigall J., Coetzee D., Cameron N. Is the Western Cape at risk of an outbreak of preventable childhood diseases? Lessons from an evaluation of routine immunisation coverage. S Afr Med J 2008, 98(January (1)):41-45.
13. Brighton Collaboration. Immunize safely. Available from ; 2010 [accessed February 2012]. http://brightoncollaboration.org/public.
14. Offit P.A., Davis R.L., Gust D. Vaccine safety. Vaccines 2003, 1629-1644. Saunders, [chapter 74]. 4th edition. S. Plotkin, W. Orenstein (Eds.).
15. Henry. Nwo polisiestaat is hier! Vaccine awakening. Available from !; November 20, 2007 [accessed February 2012]. http://www.boerevryheid.co.za/forums/showthread.php?10512-Nwo-Polisiestaat-Is-Hier.
16. Katme AM. Harms of Vaccine - time to start talking!!. Available from ; originally posted October 29, 2009 and updated April 16, 2010 [accessed February 2012]. http://samuslims.co.za/index.php%3Foption=com_content%26view=article%26id=67%3Aharms-of-vaccine-time-to-start-talking%26catid=53%3Avaccine-dangers%26Itemid=72.
17. Cape Town Smile Studios. Thimerosal and autism goes to court. Available from ; 2011 [accessed February 2012]. http://www.ctss.co.za/our-services-mainmenu-75/mercury-toxcity-mainmenu-76/thimerosal-and-autism.html.
18. Nasir L. Reconnoitering the antivaccination web sites: news from the front. J Fam Pract 2000, 49(August (8)):731-733.
19. Wolfe R.M., Sharp L.K., Lipsky M.S. Content and design attributes of antivaccination web sites. JAMA 2002, 287(June 26 (24)):3245-3248.
20. Schlafly P (citing Mercola J). Who decides what drugs are forced on children?. Available from ; March 26, 2009 [accessed February 2012]. http://www.healthycells.co.za/articles.asp?id=35.
21. Hayes T. Why we don't vaccinate. Available from ; last updated November 23, 2010 [accessed February 2012]. http://www.hayesfamily.co.za/blog/?page_id=1190.
22. Davies P., Chapman S., Leask J. Antivaccination activists on the world wide web. Arch Dis Child 2002, 87(July (1)):22-25.
23. Zimmerman R.K., Wolfe R.M., Fox D.E., Fox J.R., Nowalk M.P., Troy J.A., et al. Vaccine criticism on the World Wide Web. J Med Internet Res 2005, 7(June 29 (2)):e17.
24. Kata A A postmodern Pandora's box: anti-vaccination misinformation on the Internet. Vaccine 2010, 28(February 17 (7)):1709-1716. [Epub 2009 December 30].
25. Bean S.J. Emerging and continuing trends in vaccine opposition website content. Vaccine 2011, 29(Febuary 24 (10)):1874-1880. [Epub 2011 Jan 14].
26. Nkonki L.L., Chopra M., Doherty T.M., Jackson D., Robberstad B. Explaining household socio-economic related child health inequalities using multiple methods in three diverse settings in South Africa. Int J Equity Health 2011 April 4, 10:13.
27. Wakefield A.J., Murch S.H., Anthony A., Linnell J., Casson D.M., Malik M., et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998, 351(Febraury 28 (9103)):637-641.
28. Amanna I., Slifka M.K. Public fear of vaccination: separating fact from fiction. Viral Immunol 2005, 18(2):307-315.
29. Wroe A.L., Bhan A., Salkovskis P., Bedford H. Feeling bad about immunising our children. Vaccine 2005, 23(Febraury 10 (12)):1428-1433.
30. Gerber J.S., Offit P.A. Vaccines and autism: a tale of shifting hypotheses. Clin Infect Dis 2009, 48(Febraury 15 (4)):456-461.
31. Peltola H., Patja A., Leinikki P., Valle M., Davidkin I., Paunio M. No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet 1998, 351(May 2 (9112)):1327-1328.
32. Taylor B., Miller E., Farrington C.P., Petropoulos M.C., Favot-Mayaud I., Li J., et al. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet 1999, 353(June 12 (9169)):2026-2029.
33. Patja A., Davidkin I., Kurki T., Kallio M.J., Valle M., Peltola H. Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up. Pediatr Infect Dis J 2000, 19(December (12)):1127-1134.
34. Farrington C.P., Miller E., Taylor B. MMR and autism: further evidence against a causal association. Vaccine 2001, 19(June 14 (27)):3632-3635.
35. Kaye J.A., del Mar Melero-Montes M., Jick H. Mumps measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. BMJ 2001, 322(Febraury 24 (7284)):460-463.
36. Dales L., Hammer S.J., Smith N.J. Time trends in autism and in MMR immunization coverage in California. JAMA 2001, 285(March 7 (9)):1183-1185.
37. DeWilde S., Carey I.M., Richards N., Hilton S.R., Cook D.G. Do children who become autistic consult more often after MMR vaccination?. Br J Gen Pract 2001, 51(March (464)):226-227.
38. Fombonne E., Chakrabarti S. No evidence for a new variant of measles-mumps-rubella-induced autism. Pediatrics 2001, 108(October (4)):E58.
39. Taylor B., Miller E., Lingam R., Andrews N., Simmons A., Stowe J. Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study. BMJ 2002, 324(Febraury 16 (7334)):393-396.
40. Mäkelä A., Nuorti J.P., Peltola H. Neurologic disorders after measles-mumps-rubella vaccination. Pediatrics 2002, 110(November (5)):957-963.
41. Madsen K.M., Hviid A., Vestergaard M., Schendel D., Wohlfahrt J., Thorsen P., et al. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med 2002, 347(November 7 (19)):1477-1482.
42. DeStefano F., Bhasin T.K., Thompson W.W., Yeargin-Allsopp M., Boyle C. Age at first measles-mumps-rubella vaccination in children with autism and school-matched control subjects: a population-based study in metropolitan Atlanta. Pediatrics 2004, 113(Febraury (2)):259-266.
43. Smeeth L., Cook C., Fombonne E., Heavey L., Rodrigues L.C., Smith P.G., et al. MMR vaccination and pervasive developmental disorders: a case-control study. Lancet 2004, 364(September 11-17 (9438)):963-969.
44. Fombonne E., Zakarian R., Bennett A., Meng L., McLean-Heywood D. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations. Pediatrics 2006, 118(July (1)):e139-e150.
45. Murch S.H., Anthony A., Casson D.H., Malik M., Berelowitz M., Dhillon A.P., et al. Retraction of an interpretation. Lancet 2004, 363:750.
46. The Lancet Retraction - ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 2010, 375(February 6 (9713)):445.
47. General Medical Council. Dr Andrew Jeremy Wakefield. Determination on Serious Professional Misconduct (SPM) and sanction. Available from ; May 24, 2010 [accessed February 2012]. http://www.gmc-uk.org/Wakefield_SPM_and_SANCTION.pdf_32595267.pdf.
48. Centers for Disease Control and Prevention. Vaccine safety. Frequently asked questions about thimerosal (ethylmercury). ; 2011 [accessed February 2012]. http://www.cdc.gov/vaccinesafety/Concerns/thimerosal/thimerosal_faqs.html.
49. Stehr-Green P., Tull P., Stellfeld M., Mortenson P.B., Simpson D. Autism and thimerosal-containing vaccines: lack of consistent evidence for an association. Am J Prev Med 2003, 25(August (2)):101-106.
50. Madsen K.M., Lauritsen M.B., Pedersen C.B., Thorsen P., Plesner A.M., Andersen P.H., et al. Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data. Pediatrics 2003, 112(September (3 Pt 1)):604-606.
51. Hviid A., Stellfeld M., Wohlfahrt J., Melbye M. Association between thimerosal-containing vaccine and autism. JAMA 2003, 290(October 1 (13)):1763-1766.
52. Verstraeten T., Davis R.L., DeStefano F., Lieu T.A., Rhodes P.H., Black S.B., et al. Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. Pediatrics 2003, 112(November (5)):1039-1048.
53. Heron J., Golding J., ALSPAC Study Team Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United Kingdom does not support a causal association. Pediatrics 2004, 114(September (3)):577-583.
54. Andrews N., Miller E., Grant A., Stowe J., Osborne V., Taylor B. Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United Kingdom does not support a causal association. Pediatrics 2004, 114(September (3)):584-591.
55. Brodie N. To vaccinate or..... Available from ; August 5, 2008 [accessed February 2012]. http://mg.co.za/article/2008-08-05-to-vaccinate-or.
56. World Health Organization. Six common misperceptions about immunization. Available from ; 2010 [accessed February 2012]. http://www.who.int/immunization_safety/aefi/immunization_misconceptions/en/index.html.
57. Ginger. Much ado about measles. Available from ; October 16, 2009 [accessed February 2012]. http://www.news24.com/MyNews24/Letters/Much-ado-about-measles-20091016.
58. Tenpenny S. Reasons to just say no to vaccines. Available from ; 9 July, 2008 [accessed February 2012]. http://www.newswithviews.com/Tenpenny/sherri19.htm.
59. World Health Organization. State of the world's vaccines and immunization. Available from ; 2009 [accessed February 2012]. http://whqlibdoc.who.int/publications/2009/9789241563864_eng.pdf.
60. Coleman M.S., Lindley M.C., Ekong J., Rodewald L. Net financial gain or loss from vaccination in pediatric medical practices. Pediatrics 2009, 124(December (5)):S472-S491.
61. Freed G.L., Cowan A.E., Clark S.J. Primary care physician perspectives on reimbursement for childhood immunizations. Pediatrics 2009, 124(December (5)):S466-S471.
62. Duclos P. National Immunization Technical Advisory Groups (NITAGs): guidance for their establishment and strengthening. Vaccine 2010, 28(April 19 (1)):A18-A25.
63. Schoub B.D., Ngcobo N.J., Madhi S. The National Advisory Group on Immunization (NAGI) of the Republic of South Africa. Vaccine 2010, 28(April 19 (1)):A31-A34.
64. World Health Organization. WHO vaccine-preventable diseases: monitoring system 2010 global summary. WHO/IVB/2010. ; 2010 [accessed February 2012]. http://whqlibdoc.who.int/hq/2010/WHO_IVB_2010_eng.pdf.
65. Heininger U. The success of immunization-shovelling its own grave?. Vaccine 2004, 22(May 7 (15-16)):2071-2072.
66. André F.E. Vaccinology: past achievements, present roadblocks and future promises. Vaccine 2003, 21(January 30 (7-8)):593-595.
67. Centers for Disease Control and Prevention. Vaccines and immunizations. Some common misperceptions. ; 2011 [accessed February 2012]. http://www.cdc.gov/vaccines/vac-gen/6mishome.htm.
68. Waisbord S, Larson HJ. Why invest in communication for immunisation? Evidence and lessons learned. A joint publication of the Health Communication Partnership based at Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs (Baltimore) and the United Nations Children's Fund (New York); 2005.
69. Rowan K.E. Explaining illness through the mass media: a problem-solving perspective. Explaining illness: research, theory, and strategies 2000, Lawrence Erlbaum Associates. B.B. Whaley (Ed.).